Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.47 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.47 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.33 |
| ▸ | FDPS | P14324 | 2/20 | 0.33 |
| ▸ | ATM | Q13315 | 2/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2048398 | 0.93 | CYP4F2 (0.42) | CYP4F2CYP4A11GRM4MEN1KMT2A | |
| SCHEMBL2052355 | 0.91 | CYP4F2 (0.56) | CYP4F2CYP4A11GRM4MEN1KMT2A | |
| SCHEMBL29104226 | 0.86 | CYP4F2 (0.60) | CYP4F2CYP4A11MEN1KMT2AATM | |
| SCHEMBL2047336 | 0.83 | CYP4F2 (0.47) | CYP4F2CYP4A11GRM4MEN1KMT2A | |
| SCHEMBL9152058 | 0.82 | CYP4F2 (0.66) | CYP4F2CYP4A11MEN1KMT2AATM | |
| SCHEMBL2687299 | 0.81 | GRM4 (0.37) | CYP4F2CYP4A11GRM4LPAR3FDPS | |
| SCHEMBL2239463 | 0.81 | CYP4F2 (0.41) | CYP4F2CYP4A11GRM4LPAR3FDPS | |
| SCHEMBL2238644 | 0.81 | CYP4F2 (0.43) | CYP4F2CYP4A11MEN1KMT2AFDPS | |
| SCHEMBL2047345 | 0.81 | CYP4F2 (0.49) | CYP4F2CYP4A11MEN1KMT2ALPAR3 | |
| SCHEMBL2044329 | 0.81 | CYP4F2 (0.49) | CYP4F2CYP4A11MEN1KMT2ALPAR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6376512-B1 | FOR TREATING PHYSIOLOGICAL CONDITION IN PATIENT WHEREIN SAID CONDITION IS ASSOCIATED WITH A PHYSIOLOGICALLY DETRIMENTAL LEVELS OF INSULIN, GLUCOSE, FREE FATTY ACIDS, OR TRIGLYCERIDES | AVENTIS PHARMA DEUTSCHLAND GMBH (DE) | 2002-04-23 | — | — | US | disclosed |
| EP-0315399-B1 | Quinoline derivatives, their use in the treatment of hypersensitive ailments and a pharmaceutical composition containing the same | RHONE POULENC RORER INT (US) | 1996-01-10 | — | — | EP | disclosed |
| US-5059610-A | QUINOLINE DERIVATIVES AND THEIR USE AS ANTAGONISTS OF LEUKOTRIENE D4 | RHONE-POULENC RORER PHARMACEUTICALS INC. (US) | 1991-10-22 | — | — | US | disclosed |
| US-4920132-A | Quinoline derivatives and use thereof as antagonists of leukotriene D4 | RORER PHARMACEUTICAL CORP. (US) | 1990-04-24 | — | — | US | disclosed |